Published December 2004
| Version v1
Journal article
The role of PET in staging non-small cell lung cancer
Description
Lung cancer has become a leading cause of cancer death in Korea. Accurate staging of non-small cell lung cancer (NSCLC) is essential to the ability to offer a patient the most effective available treatment and the best estimate of prognosis. PET with F-18 fluorodeoxyglucose (FDG) is indicated for the nodal staging of NSCLC and detection of distant metastases. Use of PET for mediastinal staging should not be relied on as a sole staging modality, and positive findings should be confirmed by mediastinoscopy. FDG PET avoids futile surgery by a more accurate selection of patients, especially by the detection of unexpected distant metastases
Additional details
Publishing Information
- Journal Title
- Korean Journal of Nuclear Medicine
- Journal Volume
- 38
- Journal Issue
- 6
- Series
- 35 refs, 3 figs, 2 tabs
- Journal Page Range
- p. 481-485
- ISSN
- 1225-6714
INIS
- Country of Publication
- Korea, Republic of
- Country of Input or Organization
- Korea, Republic of
- INIS RN
- 36036329
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- FLUORINE 18; LUNGS; MEDIASTINUM; NEOPLASMS; PATIENTS; POSITRON COMPUTED TOMOGRAPHY; SURGERY; TUMOR CELLS
- Descriptors DEC
- ANIMAL CELLS; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; CHEST; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DISEASES; EMISSION COMPUTED TOMOGRAPHY; FLUORINE ISOTOPES; HOURS LIVING RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LIGHT NUCLEI; MEDICINE; NANOSECONDS LIVING RADIOISOTOPES; NUCLEI; ODD-ODD NUCLEI; ORGANS; RADIOISOTOPES; RESPIRATORY SYSTEM; TOMOGRAPHY